GO
Loading...

Biogen Idec Inc

More

  • Midday Glance: Biotechnology companies Friday, 10 Oct 2014 | 1:19 PM ET

    Amgen Inc. rose $1.99 or 1.4 percent, to $139.57. Biogen Idec rose $2.70 or. 8 percent, to $321.89. Celgene Corp. rose$. 47 or. 5 percent, to $92.85.

  • Early Glance: Biotechnology companies Friday, 10 Oct 2014 | 10:28 AM ET

    Amgen Inc. rose $2.48 or 1.8 percent, to $140.06. Biogen Idec rose $4.17 or 1.3 percent, to $323.36. Celgene Corp. rose$. 40 or. 4 percent, to $92.78.

  • Final Glance: Biotechnology companies Thursday, 9 Oct 2014 | 6:01 PM ET

    Amgen Inc. fell $2.49 or 1.8 percent, to $137.58. Biogen Idec fell $5.40 or 1.7 percent, to $319.19. Celgene Corp. fell $2.51 or 2.6 percent, to $92.38.

  • Midday Glance: Biotechnology companies Thursday, 9 Oct 2014 | 2:06 PM ET

    Amgen Inc. fell $2.06 or 1.5 percent, to $138.01. Biogen Idec fell $6.40 or 2.0 percent, to $318.19. Celgene Corp. fell $2.29 or 2.4 percent, to $92.60.

  • Early Glance: Biotechnology companies Thursday, 9 Oct 2014 | 11:31 AM ET

    Amgen Inc. fell$. 91 or. 6 percent, to $139.16. Biogen Idec fell $3.36 or 1.0 percent, to $321.23. Celgene Corp. fell $1.08 or 1.1 percent, to $93.81.

  • Final Glance: Biotechnology companies Wednesday, 8 Oct 2014 | 6:02 PM ET

    Amgen Inc. rose $4.04 or 3.0 percent, to $140.07. Biogen Idec rose $8.67 or 2.7 percent, to $324.59. Celgene Corp. rose $2.44 or 2.6 percent, to $94.89.

  • Midday Glance: Biotechnology companies Wednesday, 8 Oct 2014 | 1:33 PM ET

    Amgen Inc. rose $1.67 or 1.2 percent, to $137.70. Biogen Idec rose $1.09 or. 3 percent, to $317.01. Celgene Corp. rose$. 29 or. 3 percent, to $92.74.

  • Early Glance: Biotechnology companies Wednesday, 8 Oct 2014 | 10:52 AM ET

    Amgen Inc. rose$. 59 or. 4 percent, to $136.62. Biogen Idec fell $2.67 or. 8 percent, to $313.25. Celgene Corp. fell$. 22 or. 2 percent, to $92.23.

  • LONDON, Oct 8- A pioneering cannabis drug developed by British firm GW Pharmaceuticals for treating spasticity in multiple sclerosis has been rejected as not cost-effective in the company's home market. The National Institute for Health and Care Excellence, which determines if medicines are worth using on England's state health service, said on Wednesday...

  • Final Glance: Biotechnology companies Tuesday, 7 Oct 2014 | 6:59 PM ET

    Amgen Inc. fell $1.58 or 1.1 percent, to $136.03. Biogen Idec fell $9.15 or 2.8 percent, to $315.92. Celgene Corp. fell $2.06 or 2.2 percent, to $92.45.

  • Midday Glance: Biotechnology companies Tuesday, 7 Oct 2014 | 1:16 PM ET

    Amgen Inc. fell$. 85 or. 6 percent, to $136.76. Biogen Idec fell $6.25 or 1.9 percent, to $318.83. Celgene Corp. fell $1.63 or 1.7 percent, to $92.87.

  • Early Glance: Biotechnology companies Tuesday, 7 Oct 2014 | 10:28 AM ET

    Amgen Inc. fell$. 50 or. 4 percent, to $137.11. Biogen Idec fell $6.05 or 1.9 percent, to $319.03. Celgene Corp. fell$. 96 or 1.0 percent, to $93.54.

  • US STOCKS-Biotechs climb after two-day drop Wednesday, 24 Sep 2014 | 1:48 PM ET

    NEW YORK, Sept 24- Biotech stocks are moving higher on Wednesday, bouncing back from a two-day drop, helped by gains in Gilead Sciences after trial results for the company's HIV treatment.

  • Aug 27- Roche Holding AG's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its buck.

  • Bankers and lawyers providing takeover advice said on Monday that Burger King Worldwide Inc's intention to move its tax domicile overseas through a so-called inversion deal- in this case the purchase of Canada's Tim Hortons- shouldn't be seen as a sign of a lot more deals to come.

  • Aug 21- Baxter International Inc said a more potent version of its flagship blood disorder drug Advate met the main goal in a late-stage study.

  • ALS stunned by millions of dollars     Friday, 15 Aug 2014 | 7:36 AM ET
    Guests on "The Tonight Show Starring Jimmy Fallon" participate in the 'Ice Bucket Challenge' on August 12, 2014.

    Lance Slaughter from the ALS Association, discusses the phenomenon spreading across social media to dump a bucket of ice over your head to raise awareness for ALS.

  • What is ALS?     Friday, 15 Aug 2014 | 7:32 AM ET

    CNBC's Meg Tirrell explains what ALS, or Lou Gehrig's disease is, and what is known about treating the disease.

  • Cramer: Why the Street is preparing for the worst Wednesday, 13 Aug 2014 | 6:08 PM ET

    Cramer often look inside the market for insights on broad sentiment. And certain things happened on Wednesday that suggest trouble.

  • Traders work on the floor of the New York Stock Exchange, Aug. 1, 2014, in New York.

    U.S. stocks closed higher for the third time in four days as a rally in tech, airlines and biotech firms helped lead gains.